Idera Pharmaceuticals Inc (IDRA)

[binchey]

clearly great data

1 - DLBCL trial will show favorable results too (same type or targets)

2 -Higher doses increase worked better, this is a big plus

3 - 8400 is very well tolerated, another higher dosed trial in near future might provide even a slum drunk kind of results :)